Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Qiagen N.V.

Qiagen N.V. (QGEN) Stock Overview

Explore Qiagen N.V.’s financial performance, market position, analyst ratings, and future outlook.

QGEN●NYSE
HealthcareMedical - Diagnostics & Research
$41.95
$0.38(0.89%)
U.S. Market opens in 13h 59m

Qiagen N.V. (QGEN)

Meyka AI Score

Z

Key Financials

Market Cap8.7B
P/E Ratio22.07
EPS (TTM)$2.40
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$37.73
3 Months$32.63
1 Year Target$45.17

QGEN Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Qiagen N.V. (NYSE: QGEN) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Qiagen N.V.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of QGEN on the NYSE shows an RSI of 58.61, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $45.17 for the NYSE listing.

Key metrics behind Qiagen N.V.'s NYSE-traded stock include a P/E ratio of 22.07 and a market capitalization of 8.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of QGEN on the NYSE.

Price Performance (NYSE: QGEN)

1-Day Change
-0.91%
5-Day Change
1.94%
1-Month Change
7.13%
3-Month Change
23.35%
6-Month Change
-18.13%
Year-to-Date (YTD) Change
-11.41%
1-Year Change
-16.04%
3-Year Change
-7.93%
5-Year Change
-21.09%
All-Time (Max) Change
2018.18%

Contact Information

https://www.qiagen.com
31 77 355 6600
Hulsterweg 82, Venlo, LI, 5912 PL

Company Facts

57,360 Employees
IPO DateJun 28, 1996
CountryNL
Actively Trading

Frequently Asked Questions